Childhood rare lung disease in the 21st century: "-omics" technology advances accelerating discovery.

Pediatric Pulmonology
Timothy J VeceJames S Hagood

Abstract

Childhood rare lung diseases comprise a large number of heterogeneous respiratory disorders that are individually rare but are collectively associated with substantial morbidity, mortality, and healthcare resource utilization. Although the genetic mechanisms for several of these disorders have been elucidated, the pathogenesis mechanisms for others remain poorly understood and treatment options remain limited. Childhood rare lung diseases are enriched for genetic etiologies; identification of the disease mechanisms underlying these rare disorders can inform the biology of normal human lung development and has implications for the treatment of more common respiratory diseases in children and adults. Advances in "-omics" technology, such as genomic sequencing, clinical phenotyping, biomarker discovery, genome editing, in vitro and model organism disease modeling, single-cell analyses, cellular imaging, and high-throughput drug screening have enabled significant progress for diagnosis and treatment of rare childhood lung diseases. The most striking example of this progress has been realized for patients with cystic fibrosis for whom effective, personalized therapies based on CFTR genotype are now available. In this chapter, we foc...Continue Reading

References

Feb 11, 1993·The New England Journal of Medicine·L M NogeeH R Colten
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Feb 24, 2001·The New England Journal of Medicine·L M NogeeJ A Whitsett
Mar 7, 2001·Human Molecular Genetics·S SunyaevP Bork
May 5, 2001·Genome Research·P C Ng, S Henikoff
Mar 27, 2004·The New England Journal of Medicine·Sergey ShuleninMichael Dean
May 11, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Rajni ChibbarEdmond G Lemire
Aug 30, 2005·The Journal of Clinical Investigation·Nicoletta PedemonteA S Verkman
Sep 8, 2006·Pediatric Radiology·Alan S Brody, Eric J Crotty
Sep 22, 2007·American Journal of Respiratory and Critical Care Medicine·Gail H DeutschUNKNOWN ChILD Research Co-operative
Jan 11, 2008·The New England Journal of Medicine·John J BisslerDavid N Franz
May 14, 2008·Current Opinion in Pediatrics·Siby P Moonnumakal, Leland L Fan
Jan 21, 2009·Nature Reviews. Drug Discovery·Alan S Verkman, Luis J V Galietta
Apr 2, 2009·The European Respiratory Journal·K M AntoniouN M Siafakas
Apr 7, 2009·American Journal of Human Genetics·Helen V FirthNigel P Carter
Oct 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Fredrick Van GoorPaul Negulescu
Nov 19, 2010·The New England Journal of Medicine·Frank J AccursoBonnie W Ramsey
Jul 22, 2011·Science Signaling·Ma Xenia G IlaganRaphael Kopan
Nov 4, 2011·The New England Journal of Medicine·Bonnie W RamseyUNKNOWN VX08-770-102 Study Group
Dec 27, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Rebecca M BaronAugustine M K Choi
Mar 1, 2010·Pediatric Allergy, Immunology, and Pulmonology·Robin R Deterding
Mar 1, 2010·Pediatric Allergy, Immunology, and Pulmonology·Timothy J Vece, Leland L Fan
Mar 1, 2010·Pediatric Allergy, Immunology, and Pulmonology·R Paul Guillerman
Nov 21, 2012·Pediatrics·Jennifer A WambachAaron Hamvas
Dec 5, 2012·Cold Spring Harbor Perspectives in Medicine·Michael R Knowles, Mitchell Drumm
Aug 1, 2013·Nature Methods·Toby J GibsonReiner A Veitia
Aug 3, 2013·American Journal of Respiratory and Critical Care Medicine·Geoffrey KurlandUNKNOWN American Thoracic Society Committee on Childhood Interstitial Lung Disease (chILD) and the chILD Research Network
Jan 17, 2014·The Lancet. Respiratory Medicine·Michael P Boyle, Kris De Boeck
May 30, 2014·American Journal of Respiratory and Critical Care Medicine·Jennifer A WambachLawrence M Nogee
Jul 24, 2014·Methods in Molecular Biology·Ma Xenia G Ilagan, Raphael Kopan
Dec 11, 2014·American Journal of Respiratory and Critical Care Medicine·Stephanie D DavisMargaret W Leigh
Mar 6, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sue RichardsUNKNOWN ACMG Laboratory Quality Assurance Committee
Mar 19, 2015·European Journal of Human Genetics : EJHG·Donatella PecaOlivier Danhaive
Apr 1, 2015·Genetics·Lea M StaritaStanley Fields

❮ Previous
Next ❯

Citations

Dec 30, 2021·Pediatric Pulmonology·Timothy J VeceWilliam A Gower

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Orphanet Journal of Rare Diseases
Julia SchaeferSylvia Thun
Nature Reviews. Genetics
Konrad J Karczewski, Michael P Snyder
European Child & Adolescent Psychiatry
Franziska DegenhardtJohannes Hebebrand
© 2022 Meta ULC. All rights reserved